Fourteen patients with DSM-III social phobia were treated with
alprazolam in an open study. Multiple measures of symptoms and disability
showed significant improvement. The symptoms improved during the first and
second weeks, and disability improved at 3 weeks and beyond. After
medication withdrawal the symptom and disability measures were no longer
significantly different from those at baseline.